TGFB1 and diabetes mellitus: The intersection of pathways that changed in both non-DM and DMED patients was identified, and “TGF-β signalling”, “ECM–receptor interaction” and “protein targeting” were activated, while “FoxO signalling”, “mineral absorption” and the “Hippo signalling pathway” were significantly inhibited in ED patients (Supplementary Fig. 13a).